Revision history of "Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients." (Q34522032)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 December 2023

7 October 2023

22 March 2023

15 November 2022

25 July 2020

20 January 2020

14 January 2020

23 December 2019

25 September 2019

11 June 2019

4 March 2019

9 February 2019

23 January 2019

22 November 2018

8 September 2018

9 October 2017

  • curprev 07:4307:43, 9 October 2017 Emijrpbot talk contribs 31,915 bytes +4,693 Updated Item: BOT - Adding descriptions (57 languages): ar, ast, bg, bn, ca, cs, da, de, el, eo, es, et, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nl, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cy... undo (restore)

2 August 2017